Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia (Homo sapiens)
From WikiPathways
Description
Metapathway for the diseases lipodystrophy, dyslipidemia, hyperlipidemia and hypolipoproteinemia.
Quality Tags
Ontology Terms
Bibliography
View all... |
- Davidson, MH, Pulipati, VP; ''Hypolipidemia''; MSD MANUAL Professional Version, https://www.msdmanuals.com/professional/endocrine-and-metabolic-disorders/lipid-disorders/hypolipidemia, 2019
- Geller AS, Polisecki EY, Diffenderfer MR, Asztalos BF, Karathanasis SK, Hegele RA, Schaefer EJ; ''Genetic and secondary causes of severe HDL deficiency and cardiovascular disease.''; J Lipid Res, 2018 PubMed Europe PMC Scholia
- Akinci B, Sahinoz M, Oral E; ''Lipodystrophy Syndromes: Presentation and Treatment''; , 2000 PubMed Europe PMC Scholia
- Garg A; ''Clinical review#: Lipodystrophies: genetic and acquired body fat disorders.''; J Clin Endocrinol Metab, 2011 PubMed Europe PMC Scholia
- Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, Stalenhoef AF; ''Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.''; J Clin Endocrinol Metab, 2012 PubMed Europe PMC Scholia
- Chait A, Brunzell JD; ''Acquired hyperlipidemia (secondary dyslipoproteinemias).''; Endocrinol Metab Clin North Am, 1990 PubMed Europe PMC Scholia
- Quispe R, Hendrani AD, Baradaran-Noveiry B, Martin SS, Brown E, Kulkarni KR, Banach M, Toth PP, Brinton EA, Jones SR, Joshi PH; ''Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7.''; Arch Med Sci, 2019 PubMed Europe PMC Scholia
- Welty FK; ''Hypobetalipoproteinemia and abetalipoproteinemia.''; Curr Opin Lipidol, 2014 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
Acquired Partial Lipodystrophy | Pathway | WP5104 (WikiPathways) | |
Congenital Generalized Lipodystrophy (CGL) | Pathway | WP5101 (WikiPathways) | |
Dyslipidemia | Q66291209 (Wikidata) | DISEASE | |
Familial Partial Lipodystrophy (FPLD) | Pathway | WP5102 (WikiPathways) | |
Hyperlipidemia | Q1079120 (Wikidata) | DISEASE | |
Hypolipoproteinemia | Q5959735 (Wikidata) | DISEASE | |
Lipodystrophy | Q1538213 (Wikidata) | DISEASE | |
Progeria Associated Lipodystrophy | Pathway | WP5103 (WikiPathways) | |
Type III | Pathway | WP5110 (WikiPathways) | |
Type II | Pathway | WP5109 (WikiPathways) | |
Type IV | Pathway | WP5111 (WikiPathways) | |
Type I | Pathway | WP5108 (WikiPathways) | |
Type V | Pathway | WP5112 (WikiPathways) |
Annotated Interactions
No annotated interactions